19 novembre 2024 | 31:35 mins.
Webinar Series
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
In this insightful webinar you will gain a comprehensive overview of the advertising restrictions in the life sciences sector, with a particular focus on the prohibition of misleading advertising. Learn valuable tips and tricks to effectively communicate your message while adhering to strict regulations.
Our expert, Angela, also provides you with a detailed checklist to help assess whether your scientific evidence is robust enough to support your claims. Additionally, we explore potential repercussions of making exaggerated claims and how to maintain composure when facing a warning letter.
Dans cette série
Coffee Break Life Sciences | Overview page
Navigating the revised EU Urban Wastewater Treatment Directive | Coffee Break Life Sciences #1
17 January 2025
Regulatory Peculiarities |Coffee Break Life Sciences Start Ups #12
20 December 2024
Website, Social Media, Advertising & Co. | Coffee Break Life Sciences Start-ups #11
19 November 2024
Think big – possible exit strategies | Coffee Break Life Sciences Start-ups #10
20 October 2024
Data Protection for Life Sciences start-ups, particularly in connection with clinical trials | Coffee Break Life Sciences Start-ups #9
27 September 2024
Clinical trials in the medical devices area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #8
22 August 2024
Clinical trials in the pharmaceutical area: tips and tricks for CTA negotiations | Coffee Break Life Sciences Start-ups #7
18 July 2024
Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6
26 June 2024
Employment Law in a Nutshell | Coffee Break Life Sciences Start-ups #5
15 May 2024
par Dr. Jan W. Grawe
R&D Collaborations | Coffee Break Life Sciences Start-ups #4
18 April 2024
Tips and tricks for your financing round | Coffee Break Life Sciences Start-ups #3
20 March 2024
Don’t forget: Early stage IP strategy | Coffee Break Life Sciences Start-ups #2
23 February 2024
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
30 January 2024
Related Insights
Consulting Agreements: Dos and Don’ts | Coffee Break Life Sciences Start-ups #6
IP: Licensing and insolvency
par plusieurs auteurs